Shanghai North Carolina's wholly-owned acquisition of Anhui Zhongwang Jianfeng Pharmaceutical API Base is beginning to take shape.
Release time:
2020-07-31
News from our newspaper 8# April 3 , Shanghai Beika Pharmaceutical Technology Co., Ltd., a subsidiary of Jianfeng Pharmaceutical Co., Ltd., signed an equity transfer agreement with shareholders of Anhui Zhongwang Pharmaceutical Co., Ltd. to invest ,2062 yuan to acquire all 100% shares of the company. This is another important move to build a production base for API after the acquisition of equity in Shanghai North Carolina at the beginning of the year.
Anhui Zhongwang is located in Xiangyu Chemical Park, Dongzhi County, Chizhou City, Anhui Province. It is a pharmaceutical intermediate manufacturing enterprise integrating R & D, production and sales, focusing on characteristic medicine, intermediates, new materials, etc. R & D, production and sales of fine chemicals. The main business activities are the production and sales of 92% potassium hydrogen fluoride and 8% potassium fluoride mixture, ethyl acetate, aqueous DMF , aqueous triethylamine, toluene, methanol, acetic acid, DMF , triethylamine, industrial sodium chloride, chemical products (except hazardous chemicals and explosives); Research and development of biopharmaceuticals, chemical raw materials, pharmaceutical intermediates and fine chemicals. The company has two ofloxacin carboxylic acid production lines with a total production capacity of 1200 tons / years, and its supporting safety, environmental protection, storage and management systems, and has passed ISO9001 : 2015 quality management system certification, ISO14001 : 2015 environmental management system certification, OHSAS18001 : 2015 occupational health and safety management system certification and safety three-level standardization construction; the main products, oxyfluorocarboxylate, oxyfluorocarboxylate, levooxyfluorocarboxylate and levooxyfluorocarboxylate, passed the on-site audit of well-known domestic pharmaceutical enterprises, levofluorocarboxylate passed the on-site audit of Indian pharmaceutical enterprises, and received the on-site audit of oxyfluorocarboxylate process verification from U.S. pharmaceutical enterprises in 2017 , and was expected to be registered in U.S. document DMF as a supplier of oxyfluorocarboxylate starting materials. The equity acquisition of Anhui Zhongwang is an important measure to strengthen the development of the pharmaceutical business sector according to the company's strategic policy of "strengthening the main business through cooperation and innovation, standardizing science and seeking development. After the acquisition, Anhui Zhongwang will become a wholly-owned subsidiary of Shanghai Beika. The company plans to use the factory building and construction land of Anhui Zhongwang to plan the construction of pharmaceutical intermediates and API projects, which is conducive to the overall layout of Jianfeng Pharmaceutical's chemical API base in Anhui: the pesticide and primary pharmaceutical intermediates will be arranged in the factory area of Anhui Xinbeika Chemical Co., Ltd., and the API and advanced pharmaceutical intermediates will be arranged in the factory area of Anhui Zhongwang, it can make full use of Anhui Zhongwang's factory area, public engineering facilities, quality management system and other advantages to speed up the construction progress of Jianfeng Pharmaceutical Anhui Chemical Raw Material Drug Base. In addition, the acquisition of Anhui Zhongwang will also help expand the R & D, production and sales of Shanghai North Carolina's existing fine chemicals business such as intermediates and new materials, further extend and improve the industrial chain, and consolidate its market position. (this newspaper reporter)
More information
The company's vocational skill level independently identifies two new occupations
A few days ago, after the examination and approval of the Jinhua Municipal Bureau of Human Resources and Social Security, and reported to the Provincial Department of Human Resources and Social Security for examination and filing, Jianfeng Group's independent identification level of vocational skills was based on last year. Two new occupations (types of work) are chemical inspectors and organic synthesis workers.
2022
05-20
On May 12, Cai Xiaochun, deputy secretary of the Party group of Zhejiang Federation of industry and commerce, and his party visited Jianfeng group for investigation, visited Jinxi factory area of Jianfeng pharmaceutical factory and Jinxi internationalization project site, and had a discussion with Jiang Xiaomeng, chairman of the group company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company.
2022
05-20
On the afternoon of April 6, Jiang Xiaomeng, chairman of the group company, was invited to participate in the Jinhua News Client Financial Media Interview column "Night Talk of the Two Sessions", as a representative of the Jinhua Municipal People's Congress, to talk about suggestions for the future development of Jinhua enterprises. As the chairman of the Jinhua City Federation of Industry and Commerce, Jiang Xiaomeng has a personal experience of various problems encountered in the development of Jinhua enterprises. After careful investigation and full preparation, he put forward two proposals on strengthening the empowerment and allocation of production factors and further enhancing the market competitiveness of enterprises in our city and further promoting the compliance construction of private enterprises in our city and reducing the risk of enterprise operation. In the "two sessions night talk" interview, he put forward his own views on these two topics.
2022
04-12
Group Companies Commend 2021 Advanced
On the morning of January 26, the group company held the 2021 annual summary commendation meeting to review the work of the previous year, make arrangements for the work of 2022, sign the 2022 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2021 advanced collectives and individuals.
2022
02-08
Group Company Convenes Workers' Representative and Trade Union Member Representative Conference
The group company held a representative meeting of staff representatives and trade union members, elected members of the eighth trade union committee and members of various special committees, and Shi Fu was elected chairman of the eighth trade union of the group trade union.
2022
02-08
The group company held an annual safety and environmental protection work conference to comprehensively summarize and review the safety and environmental protection work in 2021, make arrangements for the safety and environmental protection work in 2022, and sign the safety and environmental protection work responsibility system.
2022
02-08